cyclopentane has been researched along with Nausea in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ariyasu, Y; Ishii, S; Itoh, Y; Komeda, T; Sanekata, M; Shimada, J; Yoshikawa, T | 1 |
| Barroso, L; Gubareva, L; Hayden, FG; Treanor, J | 1 |
1 trial(s) available for cyclopentane and Nausea
| Article | Year |
|---|---|
Efficacy and tolerability of the oral neuraminidase inhibitor peramivir in experimental human influenza: randomized, controlled trials for prophylaxis and treatment.
Topics: Acids, Carbocyclic; Administration, Oral; Adolescent; Adult; Cyclopentanes; Double-Blind Method; Drug Administration Schedule; Guanidines; Headache; Humans; Influenza A Virus, H1N1 Subtype; Influenza B virus; Influenza, Human; Middle Aged; Nasal Lavage Fluid; Nausea; Neuraminidase; Treatment Outcome | 2005 |
1 other study(ies) available for cyclopentane and Nausea
| Article | Year |
|---|---|
Post-marketing safety and effectiveness evaluation of the intravenous anti-influenza neuraminidase inhibitor peramivir (I): a drug use investigation.
Topics: Acids, Carbocyclic; Administration, Intravenous; Adolescent; Adult; Aged; Antiviral Agents; Cyclopentanes; Diarrhea; Female; Guanidines; Humans; Influenza, Human; Japan; Male; Middle Aged; Nausea; Neuraminidase; Product Surveillance, Postmarketing; Time Factors; Vomiting; Young Adult | 2014 |